nodes	percent_of_prediction	percent_of_DWPC	metapath
Etoricoxib—CYP2E1—Parkinson's disease	0.466	0.577	CbGaD
Etoricoxib—CYP2D6—Parkinson's disease	0.342	0.423	CbGaD
Etoricoxib—MAPK14—hindbrain—Parkinson's disease	0.00275	0.122	CbGeAlD
Etoricoxib—Vemurafenib—CYP2D6—Parkinson's disease	0.00223	0.513	CrCbGaD
Etoricoxib—MAPK14—embryo—Parkinson's disease	0.00172	0.0763	CbGeAlD
Etoricoxib—MAPK14—brainstem—Parkinson's disease	0.00158	0.0699	CbGeAlD
Etoricoxib—MAPK14—forebrain—Parkinson's disease	0.00152	0.0675	CbGeAlD
Etoricoxib—Celecoxib—CYP2D6—Parkinson's disease	0.00131	0.302	CrCbGaD
Etoricoxib—MAPK14—cardiovascular system—Parkinson's disease	0.00129	0.057	CbGeAlD
Etoricoxib—MAPK14—spinal cord—Parkinson's disease	0.00098	0.0435	CbGeAlD
Etoricoxib—MAPK14—head—Parkinson's disease	0.000871	0.0386	CbGeAlD
Etoricoxib—MAPK14—nervous system—Parkinson's disease	0.000826	0.0366	CbGeAlD
Etoricoxib—Vismodegib—ABCB1—Parkinson's disease	0.000802	0.185	CrCbGaD
Etoricoxib—MAPK14—central nervous system—Parkinson's disease	0.000795	0.0353	CbGeAlD
Etoricoxib—MAPK14—cerebellum—Parkinson's disease	0.000777	0.0345	CbGeAlD
Etoricoxib—CYP2D6—hindbrain—Parkinson's disease	0.00068	0.0302	CbGeAlD
Etoricoxib—MAPK14—brain—Parkinson's disease	0.000631	0.028	CbGeAlD
Etoricoxib—PTGS2—embryo—Parkinson's disease	0.000495	0.0219	CbGeAlD
Etoricoxib—PTGS2—forebrain—Parkinson's disease	0.000437	0.0194	CbGeAlD
Etoricoxib—CYP2C9—cardiovascular system—Parkinson's disease	0.000424	0.0188	CbGeAlD
Etoricoxib—CYP2E1—cardiovascular system—Parkinson's disease	0.000402	0.0178	CbGeAlD
Etoricoxib—CYP2D6—brainstem—Parkinson's disease	0.00039	0.0173	CbGeAlD
Etoricoxib—CYP2D6—forebrain—Parkinson's disease	0.000376	0.0167	CbGeAlD
Etoricoxib—PTGS2—cardiovascular system—Parkinson's disease	0.00037	0.0164	CbGeAlD
Etoricoxib—CYP2E1—medulla oblongata—Parkinson's disease	0.000343	0.0152	CbGeAlD
Etoricoxib—PTGS2—medulla oblongata—Parkinson's disease	0.000316	0.014	CbGeAlD
Etoricoxib—CYP2E1—spinal cord—Parkinson's disease	0.000306	0.0136	CbGeAlD
Etoricoxib—PTGS2—midbrain—Parkinson's disease	0.000289	0.0128	CbGeAlD
Etoricoxib—PTGS2—spinal cord—Parkinson's disease	0.000282	0.0125	CbGeAlD
Etoricoxib—CYP2E1—head—Parkinson's disease	0.000272	0.0121	CbGeAlD
Etoricoxib—CYP2E1—nervous system—Parkinson's disease	0.000258	0.0114	CbGeAlD
Etoricoxib—PTGS2—head—Parkinson's disease	0.00025	0.0111	CbGeAlD
Etoricoxib—CYP2E1—central nervous system—Parkinson's disease	0.000248	0.011	CbGeAlD
Etoricoxib—CYP2E1—cerebellum—Parkinson's disease	0.000243	0.0108	CbGeAlD
Etoricoxib—PTGS2—nervous system—Parkinson's disease	0.000237	0.0105	CbGeAlD
Etoricoxib—PTGS2—central nervous system—Parkinson's disease	0.000229	0.0101	CbGeAlD
Etoricoxib—PTGS2—cerebellum—Parkinson's disease	0.000223	0.00991	CbGeAlD
Etoricoxib—CYP2D6—head—Parkinson's disease	0.000215	0.00955	CbGeAlD
Etoricoxib—CYP3A4—nervous system—Parkinson's disease	0.000208	0.0092	CbGeAlD
Etoricoxib—CYP2D6—nervous system—Parkinson's disease	0.000204	0.00905	CbGeAlD
Etoricoxib—CYP3A4—central nervous system—Parkinson's disease	0.0002	0.00886	CbGeAlD
Etoricoxib—CYP2E1—brain—Parkinson's disease	0.000197	0.00874	CbGeAlD
Etoricoxib—CYP2D6—central nervous system—Parkinson's disease	0.000197	0.00872	CbGeAlD
Etoricoxib—CYP2D6—cerebellum—Parkinson's disease	0.000192	0.00852	CbGeAlD
Etoricoxib—PTGS2—brain—Parkinson's disease	0.000182	0.00805	CbGeAlD
Etoricoxib—CYP2D6—brain—Parkinson's disease	0.000156	0.00692	CbGeAlD
Etoricoxib—CYP3A4—Biological oxidations—COMT—Parkinson's disease	4.41e-05	0.000267	CbGpPWpGaD
Etoricoxib—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	4.39e-05	0.000266	CbGpPWpGaD
Etoricoxib—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	4.38e-05	0.000265	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—ND3—Parkinson's disease	4.37e-05	0.000265	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—MCCC1—Parkinson's disease	4.37e-05	0.000265	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—INS—Parkinson's disease	4.37e-05	0.000265	CbGpPWpGaD
Etoricoxib—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	4.35e-05	0.000263	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—ND3—Parkinson's disease	4.33e-05	0.000263	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—MCCC1—Parkinson's disease	4.33e-05	0.000263	CbGpPWpGaD
Etoricoxib—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	4.33e-05	0.000262	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—NDUFB11—Parkinson's disease	4.24e-05	0.000257	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—GFAP—Parkinson's disease	4.23e-05	0.000256	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—GRM5—Parkinson's disease	4.18e-05	0.000253	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—ADRBK1—Parkinson's disease	4.17e-05	0.000253	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular Senescence—IL6—Parkinson's disease	4.17e-05	0.000253	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—HSPA1A—Parkinson's disease	4.12e-05	0.000249	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—OMD—Parkinson's disease	4.11e-05	0.000249	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—TALDO1—Parkinson's disease	4.11e-05	0.000249	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	4.08e-05	0.000247	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—TALDO1—Parkinson's disease	4.07e-05	0.000247	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—OMD—Parkinson's disease	4.07e-05	0.000247	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—GCH1—Parkinson's disease	4.04e-05	0.000245	CbGpPWpGaD
Etoricoxib—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	4.03e-05	0.000244	CbGpPWpGaD
Etoricoxib—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	3.98e-05	0.000241	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	3.93e-05	0.000238	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—NDUFB11—Parkinson's disease	3.9e-05	0.000236	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—NDUFB11—Parkinson's disease	3.86e-05	0.000234	CbGpPWpGaD
Etoricoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—IL6—Parkinson's disease	3.84e-05	0.000233	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—IL6—Parkinson's disease	3.83e-05	0.000232	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—GCH1—Parkinson's disease	3.72e-05	0.000225	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—ND3—Parkinson's disease	3.7e-05	0.000224	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—MCCC1—Parkinson's disease	3.7e-05	0.000224	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—GCH1—Parkinson's disease	3.68e-05	0.000223	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—FGF20—Parkinson's disease	3.67e-05	0.000222	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	3.64e-05	0.000221	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—DDC—Parkinson's disease	3.64e-05	0.000221	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—GBA—Parkinson's disease	3.6e-05	0.000218	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—DBH—Parkinson's disease	3.6e-05	0.000218	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—FBP1—Parkinson's disease	3.6e-05	0.000218	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—RPL23A—Parkinson's disease	3.59e-05	0.000217	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—RPL14—Parkinson's disease	3.59e-05	0.000217	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—ADORA2A—Parkinson's disease	3.56e-05	0.000215	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—TALDO1—Parkinson's disease	3.48e-05	0.000211	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—OMD—Parkinson's disease	3.48e-05	0.000211	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—GSTA4—Parkinson's disease	3.44e-05	0.000208	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—DDC—Parkinson's disease	3.43e-05	0.000208	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—ABL1—Parkinson's disease	3.4e-05	0.000206	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	3.39e-05	0.000206	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—FGF20—Parkinson's disease	3.35e-05	0.000203	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—RPS8—Parkinson's disease	3.35e-05	0.000203	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	3.32e-05	0.000201	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—FBP1—Parkinson's disease	3.31e-05	0.000201	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—DBH—Parkinson's disease	3.31e-05	0.000201	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—GBA—Parkinson's disease	3.31e-05	0.000201	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—NDUFB11—Parkinson's disease	3.3e-05	0.0002	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—GBA—Parkinson's disease	3.28e-05	0.000199	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—FBP1—Parkinson's disease	3.28e-05	0.000199	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—DBH—Parkinson's disease	3.28e-05	0.000199	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—INSR—Parkinson's disease	3.28e-05	0.000199	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—GSTA4—Parkinson's disease	3.24e-05	0.000196	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	3.23e-05	0.000196	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—HGF—Parkinson's disease	3.2e-05	0.000194	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular responses to stress—IL6—Parkinson's disease	3.15e-05	0.000191	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—GCH1—Parkinson's disease	3.15e-05	0.000191	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—FGB—Parkinson's disease	3.1e-05	0.000188	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—PLA2G6—Parkinson's disease	3.09e-05	0.000188	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—HTR1A—Parkinson's disease	3.09e-05	0.000187	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—MAOB—Parkinson's disease	3.06e-05	0.000186	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—TAC1—Parkinson's disease	3.04e-05	0.000184	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—DRD1—Parkinson's disease	2.98e-05	0.000181	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by NGF—IL6—Parkinson's disease	2.95e-05	0.000179	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	2.92e-05	0.000177	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—PLA2G6—Parkinson's disease	2.91e-05	0.000177	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—DRD3—Parkinson's disease	2.89e-05	0.000175	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—MAOB—Parkinson's disease	2.88e-05	0.000175	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—MCCC1—Parkinson's disease	2.86e-05	0.000173	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—ND3—Parkinson's disease	2.86e-05	0.000173	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	2.84e-05	0.000172	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—GBA—Parkinson's disease	2.81e-05	0.00017	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—DBH—Parkinson's disease	2.81e-05	0.00017	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—FBP1—Parkinson's disease	2.81e-05	0.00017	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—ADRBK1—Parkinson's disease	2.7e-05	0.000163	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—TALDO1—Parkinson's disease	2.69e-05	0.000163	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—OMD—Parkinson's disease	2.69e-05	0.000163	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—DDC—Parkinson's disease	2.64e-05	0.00016	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—MAPK8—Parkinson's disease	2.64e-05	0.00016	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—HTR7—Parkinson's disease	2.61e-05	0.000158	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—DRD2—Parkinson's disease	2.61e-05	0.000158	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	2.55e-05	0.000154	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—GSTA4—Parkinson's disease	2.5e-05	0.000151	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	2.46e-05	0.000149	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—ADRBK1—Parkinson's disease	2.46e-05	0.000149	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—HSPA1A—Parkinson's disease	2.44e-05	0.000148	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—DDC—Parkinson's disease	2.43e-05	0.000147	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—GCH1—Parkinson's disease	2.43e-05	0.000147	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—DDC—Parkinson's disease	2.41e-05	0.000146	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—TNF—Parkinson's disease	2.36e-05	0.000143	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—GSTA4—Parkinson's disease	2.3e-05	0.000139	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—CYP2D6—Parkinson's disease	2.28e-05	0.000138	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—GSTA4—Parkinson's disease	2.28e-05	0.000138	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—PLA2G6—Parkinson's disease	2.25e-05	0.000136	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	2.25e-05	0.000136	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—CTGF—Parkinson's disease	2.23e-05	0.000135	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—MAOB—Parkinson's disease	2.23e-05	0.000135	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—IGF2—Parkinson's disease	2.19e-05	0.000133	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—DBH—Parkinson's disease	2.17e-05	0.000131	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—FBP1—Parkinson's disease	2.17e-05	0.000131	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—GBA—Parkinson's disease	2.17e-05	0.000131	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—CYP2D6—Parkinson's disease	2.14e-05	0.00013	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	2.12e-05	0.000128	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—IGF1R—Parkinson's disease	2.11e-05	0.000128	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—CTGF—Parkinson's disease	2.1e-05	0.000127	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—EDN1—Parkinson's disease	2.09e-05	0.000127	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—CYP2E1—Parkinson's disease	2.08e-05	0.000126	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	2.07e-05	0.000125	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—DDC—Parkinson's disease	2.06e-05	0.000125	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—NQO1—Parkinson's disease	2.06e-05	0.000125	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—PLA2G6—Parkinson's disease	2.05e-05	0.000124	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—MAOB—Parkinson's disease	2.05e-05	0.000124	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—TH—Parkinson's disease	2.03e-05	0.000123	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—MAOB—Parkinson's disease	2.03e-05	0.000123	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—CYCS—Parkinson's disease	1.95e-05	0.000118	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—GSTA4—Parkinson's disease	1.95e-05	0.000118	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—NQO1—Parkinson's disease	1.94e-05	0.000117	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	1.93e-05	0.000117	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	1.92e-05	0.000116	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—NGF—Parkinson's disease	1.92e-05	0.000116	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—TH—Parkinson's disease	1.91e-05	0.000116	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—IL6—Parkinson's disease	1.91e-05	0.000116	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—CYCS—Parkinson's disease	1.83e-05	0.000111	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—HTR2A—Parkinson's disease	1.83e-05	0.000111	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—PLA2G6—Parkinson's disease	1.75e-05	0.000106	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—MAOB—Parkinson's disease	1.73e-05	0.000105	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—COMT—Parkinson's disease	1.73e-05	0.000105	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—GSTP1—Parkinson's disease	1.72e-05	0.000104	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—MAOA—Parkinson's disease	1.71e-05	0.000104	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—APOE—Parkinson's disease	1.7e-05	0.000103	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—HMOX1—Parkinson's disease	1.69e-05	0.000103	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—IL6—Parkinson's disease	1.68e-05	0.000102	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IL1B—Parkinson's disease	1.68e-05	0.000102	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—MTHFR—Parkinson's disease	1.67e-05	0.000101	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—CYP2D6—Parkinson's disease	1.65e-05	0.0001	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	1.65e-05	0.0001	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—ABCB1—Parkinson's disease	1.63e-05	9.85e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—COMT—Parkinson's disease	1.62e-05	9.84e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—CTGF—Parkinson's disease	1.62e-05	9.84e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—GSTP1—Parkinson's disease	1.62e-05	9.8e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—MAOA—Parkinson's disease	1.61e-05	9.77e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—HMOX1—Parkinson's disease	1.59e-05	9.66e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—DDC—Parkinson's disease	1.59e-05	9.63e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—GSTM1—Parkinson's disease	1.58e-05	9.56e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—APOE—Parkinson's disease	1.55e-05	9.4e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—MAPK8—Parkinson's disease	1.54e-05	9.31e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—ABCB1—Parkinson's disease	1.53e-05	9.27e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—CYP2E1—Parkinson's disease	1.51e-05	9.16e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—GPX1—Parkinson's disease	1.51e-05	9.16e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—CYP2D6—Parkinson's disease	1.51e-05	9.14e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—GSTA4—Parkinson's disease	1.5e-05	9.1e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—NQO1—Parkinson's disease	1.5e-05	9.06e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—CTGF—Parkinson's disease	1.49e-05	9.05e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—GSTM1—Parkinson's disease	1.49e-05	9e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—CTGF—Parkinson's disease	1.48e-05	8.97e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—TH—Parkinson's disease	1.47e-05	8.93e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—INS—Parkinson's disease	1.45e-05	8.8e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—GPX1—Parkinson's disease	1.42e-05	8.62e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—CYCS—Parkinson's disease	1.42e-05	8.57e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—MTHFR—Parkinson's disease	1.39e-05	8.45e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	1.39e-05	8.43e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—CYP2E1—Parkinson's disease	1.38e-05	8.36e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—NQO1—Parkinson's disease	1.38e-05	8.33e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—NQO1—Parkinson's disease	1.36e-05	8.26e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—TH—Parkinson's disease	1.36e-05	8.21e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	1.35e-05	8.19e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—TH—Parkinson's disease	1.34e-05	8.14e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—MAOB—Parkinson's disease	1.34e-05	8.11e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—INS—Parkinson's disease	1.32e-05	8.03e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—MTHFR—Parkinson's disease	1.31e-05	7.96e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—CYCS—Parkinson's disease	1.3e-05	7.89e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—APOE—Parkinson's disease	1.3e-05	7.87e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—CYCS—Parkinson's disease	1.29e-05	7.82e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—CYP2D6—Parkinson's disease	1.29e-05	7.81e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—CTGF—Parkinson's disease	1.26e-05	7.66e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—COMT—Parkinson's disease	1.25e-05	7.59e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—GSTP1—Parkinson's disease	1.25e-05	7.56e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—MAOA—Parkinson's disease	1.24e-05	7.54e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—HMOX1—Parkinson's disease	1.23e-05	7.45e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—APOE—Parkinson's disease	1.22e-05	7.41e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—ABCB1—Parkinson's disease	1.18e-05	7.15e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—CYP2E1—Parkinson's disease	1.18e-05	7.14e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—NQO1—Parkinson's disease	1.17e-05	7.06e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—COMT—Parkinson's disease	1.15e-05	6.98e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—TH—Parkinson's disease	1.15e-05	6.96e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—GSTP1—Parkinson's disease	1.15e-05	6.95e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—GSTM1—Parkinson's disease	1.15e-05	6.95e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—MAOA—Parkinson's disease	1.14e-05	6.94e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—COMT—Parkinson's disease	1.14e-05	6.92e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—GSTP1—Parkinson's disease	1.14e-05	6.89e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—MAOA—Parkinson's disease	1.13e-05	6.88e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—HMOX1—Parkinson's disease	1.13e-05	6.86e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—HMOX1—Parkinson's disease	1.12e-05	6.8e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—INS—Parkinson's disease	1.11e-05	6.72e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—CYCS—Parkinson's disease	1.1e-05	6.68e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—GPX1—Parkinson's disease	1.1e-05	6.65e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—ABCB1—Parkinson's disease	1.09e-05	6.58e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CASP3—Parkinson's disease	1.08e-05	6.55e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—ABCB1—Parkinson's disease	1.08e-05	6.52e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—GSTM1—Parkinson's disease	1.05e-05	6.39e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—GSTM1—Parkinson's disease	1.05e-05	6.33e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—INS—Parkinson's disease	1.04e-05	6.33e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—MTHFR—Parkinson's disease	1.01e-05	6.14e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—GPX1—Parkinson's disease	1.01e-05	6.12e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—GPX1—Parkinson's disease	1e-05	6.06e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	9.94e-06	6.03e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—MAPK8—Parkinson's disease	9.94e-06	6.02e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IL6—Parkinson's disease	9.81e-06	5.95e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—COMT—Parkinson's disease	9.77e-06	5.92e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—CTGF—Parkinson's disease	9.76e-06	5.91e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—GSTP1—Parkinson's disease	9.72e-06	5.89e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—MAOA—Parkinson's disease	9.7e-06	5.88e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—HMOX1—Parkinson's disease	9.59e-06	5.81e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—APOE—Parkinson's disease	9.43e-06	5.71e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—MTHFR—Parkinson's disease	9.32e-06	5.65e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—MTHFR—Parkinson's disease	9.24e-06	5.6e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—ABCB1—Parkinson's disease	9.2e-06	5.57e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	9.1e-06	5.51e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—NQO1—Parkinson's disease	8.99e-06	5.45e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—GSTM1—Parkinson's disease	8.93e-06	5.41e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—TH—Parkinson's disease	8.86e-06	5.37e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—APOE—Parkinson's disease	8.67e-06	5.26e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—APOE—Parkinson's disease	8.6e-06	5.21e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—GPX1—Parkinson's disease	8.55e-06	5.18e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—CYCS—Parkinson's disease	8.51e-06	5.16e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—INS—Parkinson's disease	8.06e-06	4.88e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—MTHFR—Parkinson's disease	7.89e-06	4.78e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—COMT—Parkinson's disease	7.54e-06	4.57e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—GSTP1—Parkinson's disease	7.5e-06	4.54e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—MAOA—Parkinson's disease	7.48e-06	4.53e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—INS—Parkinson's disease	7.41e-06	4.49e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—HMOX1—Parkinson's disease	7.4e-06	4.48e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—APOE—Parkinson's disease	7.35e-06	4.45e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—INS—Parkinson's disease	7.35e-06	4.45e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—ABCB1—Parkinson's disease	7.1e-06	4.3e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—GSTM1—Parkinson's disease	6.89e-06	4.18e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—GPX1—Parkinson's disease	6.6e-06	4e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—IL6—Parkinson's disease	6.34e-06	3.84e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—INS—Parkinson's disease	6.28e-06	3.8e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—MTHFR—Parkinson's disease	6.09e-06	3.69e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—IL6—Parkinson's disease	5.79e-06	3.51e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—APOE—Parkinson's disease	5.67e-06	3.44e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—INS—Parkinson's disease	4.84e-06	2.94e-05	CbGpPWpGaD
